
Sign up to save your podcasts
Or
iRhythm Technologies’ Zio ambulatory cardiac monitors have the potential to change how doctors screen for atrial fibrillation and other arrythmias by combining miniaturized biosensors and data analytics into a wearable device, CEO Quentin Blackford explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Blackford sits down with BI analyst Matthew Henriksson for an in-depth interview to talk about iRhythm and how its systems allow patients to be monitored outside of medical offices without disrupting their everyday lives.
See omnystudio.com/listener for privacy information.
5
22 ratings
iRhythm Technologies’ Zio ambulatory cardiac monitors have the potential to change how doctors screen for atrial fibrillation and other arrythmias by combining miniaturized biosensors and data analytics into a wearable device, CEO Quentin Blackford explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Blackford sits down with BI analyst Matthew Henriksson for an in-depth interview to talk about iRhythm and how its systems allow patients to be monitored outside of medical offices without disrupting their everyday lives.
See omnystudio.com/listener for privacy information.
1,199 Listeners
2,174 Listeners
1,784 Listeners
394 Listeners
122 Listeners
771 Listeners
91 Listeners
9,189 Listeners
147 Listeners
246 Listeners
15,237 Listeners
351 Listeners
17 Listeners
461 Listeners
371 Listeners